Arrowhead Pharmaceuticals Inc (0HI3)
LSE
Fin d'année 30 Septembre 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -29.613 | -50.503 | 29.461 | -19.385 | -22.853 | -25.114 | -28.168 | -62.927 |
Return on Equity (%) | -39.092 | -61.837 | 40.071 | -23.959 | -32.356 | -42.57 | -58.193 | -250.716 |
Return on Invested Capital (%) | -39.114 | -60.182 | 42.246 | -34.926 | -60.511 | -76.722 | -68.787 | -137.672 |
Operating Margin (%) | -109.456 | -337.306 | 40.374 | -96.089 | -101.85 | -71.006 | -78.163 | -16336.469 |
Net Profit Margin (%) | -109.463 | -337.319 | 40.271 | -96.092 | -101.852 | -72.385 | -85.27 | -16882.371 |
Book Value Per Share | 0.808 | 0.864 | 2.376 | 4.36 | 3.787 | 3.835 | 2.583 | 1.468 |
Earnings Per Share | -0.46 | -0.615 | 0.712 | -0.826 | -1.35 | -1.661 | -1.915 | -4.822 |
Cash Per Share | 0.332 | 0.34 | 2.312 | 1.385 | 1.745 | 0.95 | 0.961 | 0.798 |
Working Capital Per Share | 0.658 | 0.75 | 1.761 | 2.751 | 2.282 | 2.514 | 2.929 | 4.764 |
Operating Profit Per Share | 0.42 | 0.182 | 1.767 | 0.859 | 1.325 | 2.295 | 2.245 | 0.029 |
EBIT Per Share | -0.46 | -0.615 | 0.713 | -0.826 | -1.35 | -1.63 | -1.926 | -4.926 |
EBITDA Per Share | -0.46 | -0.615 | 0.713 | -0.826 | -1.35 | -1.63 | -1.926 | -4.926 |
Free Cash Flow Per Share | -0.416 | -0.652 | 0.791 | -0.767 | -1.203 | -1.262 | -0.383 | -3.833 |
Fin d'année 30 Septembre 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 74,79M | 88,51M | 95,51M | 102,38M | 104,33M | 105,96M | N/A | N/A |
Capitalisation boursière | 1,21B |
Ratio cours/bénéfice | -4,62 |
Ratio prix/ventes | 778,67 |
Ratio prix/liquidités | 27,91 |
Ratio prix/valeur comptable | 14,49 |
Rendement de dividende | - |
Actions en circulation | 124,32M |
Volume moyen (1 semaine) | 1,05k |
Volume moyen (1 mois) | 6,51k |
Variation sur 52 semaines | 0,00% |
Plus haut sur 52 semaines | 9,77 |
Plus bas sur 52 semaines | 9,77 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales